Journal Description
Tropical Medicine and Infectious Disease
Tropical Medicine and Infectious Disease
(TropicalMed) is an international, scientific, peer-reviewed, open access journal of tropical medicine and infectious disease published monthly online by MDPI. It is the official journal of the Australasian College of Tropical Medicine (ACTM) and its Joint Faculties of Travel Medicine and Expedition and Wilderness Medicine. Their members receive discounts on the article processing charges.
- Open Access— free for readers, with article processing charges (APC) paid by authors or their institutions.
- High Visibility: indexed within Scopus, SCIE (Web of Science), PubMed, PMC, Embase, Informit, and other databases.
- Journal Rank: JCR - Q1 (Tropical Medicine) / CiteScore - Q2 (Public Health, Environmental and Occupational Health)
- Rapid Publication: manuscripts are peer-reviewed and a first decision is provided to authors approximately 20.6 days after submission; acceptance to publication is undertaken in 3.1 days (median values for papers published in this journal in the first half of 2025).
- Recognition of Reviewers: reviewers who provide timely, thorough peer-review reports receive vouchers entitling them to a discount on the APC of their next publication in any MDPI journal, in appreciation of the work done.
Impact Factor:
2.6 (2024);
5-Year Impact Factor:
2.8 (2024)
Latest Articles
Genotype Analysis on Orientia tsutsugamushi Causing Scrub Typhus in Malaysia: A Re-Emerging Disease
Trop. Med. Infect. Dis. 2025, 10(9), 252; https://doi.org/10.3390/tropicalmed10090252 - 2 Sep 2025
Abstract
Introduction: Scrub typhus is caused by Gram-negative bacteria, Orientia tsutsugamushi. Humans are the dead-end host of scrub typhus. Currently, there is no vaccine available. The disease can be fatal without appropriate treatment. Here, we present the circulating OT genotypes in Malaysia and
[...] Read more.
Introduction: Scrub typhus is caused by Gram-negative bacteria, Orientia tsutsugamushi. Humans are the dead-end host of scrub typhus. Currently, there is no vaccine available. The disease can be fatal without appropriate treatment. Here, we present the circulating OT genotypes in Malaysia and a tsa56-based single PCR to detect and determine OT genotypes, which is an approach to replace the time-consuming traditional nested PCR. Methods: The patients’ blood or tissue samples (n = 1200), received from all hospitals in Malaysia from December 2022 to November 2024, were screened for rickettsial infections. Both htrA qPCR and nested PCR were performed to detect the presence of OT DNA. Simultaneously, a selection of DNA was evaluated for the new single PCR protocol and confirmed with Sanger sequencing. Results: We report that Pahang state of Peninsular Malaysia presents the highest number of acute scrub typhus infections in Malaysia within the 24 months period. There are four genotypes circulating in the Malaysian population. OT genotype Gilliam (n = 31, 29.2%) and Karp (n = 31, 29.2%) are the predominant OT genotypes in Malaysia, followed by TA763 (n = 22, 20.8%) and Kato (n = 22, 20.8%). The single-run PCR presents longer sequence size and similar results with the nested PCR. Conclusions: Acute scrub typhus infection is not rare in Malaysia and should be considered for undifferentiated febrile illness. The single-run PCR protocol is time-saving and a promising approach for OT detection and genotype analysis in a single run to complement a clinical diagnostic setting and surveillance.
Full article
(This article belongs to the Section Vector-Borne Diseases)
►
Show Figures
Open AccessArticle
Vector-Borne Disease Control and Management in Irrigation Areas: A Neglected Critical Phenomenon in Malawi
by
Levi Kalitsilo, Rose Oronje and Nyanyiwe Masingi Mbeye
Trop. Med. Infect. Dis. 2025, 10(9), 251; https://doi.org/10.3390/tropicalmed10090251 - 2 Sep 2025
Abstract
Vector-borne diseases (VBDs) account for more than 17% of all infectious diseases, causing over 700,000 deaths annually, particularly among the poorest populations in tropical and subtropical areas. Climate change, particularly global warming, and certain human activities, including irrigation farming, exacerbate the situation by
[...] Read more.
Vector-borne diseases (VBDs) account for more than 17% of all infectious diseases, causing over 700,000 deaths annually, particularly among the poorest populations in tropical and subtropical areas. Climate change, particularly global warming, and certain human activities, including irrigation farming, exacerbate the situation by creating conducive environments that facilitate the breeding of vectors such as mosquitoes and snails. This qualitative study aimed to understand the VBD control and management policy landscape in irrigation areas by gathering perceptions from key stakeholders in the irrigation farming sector in Malawi. Respondents indicated that there are no specific VBD control and management policies targeting irrigation areas in Malawi and that stakeholders essentially work in silos. Notwithstanding this, the Malawi government is committed to expanding irrigation areas to address food security. We, therefore, call for the integration of VBD control and management in irrigation farming, utilising the One Health approach—a promising strategy that could bring significant benefits. Further, we recommend the provision of VBD control and management resources in irrigation investments and the involvement of VBD researchers in the formulation of irrigation policies.
Full article
(This article belongs to the Special Issue One Health Approach to Mosquito-Borne Diseases: Epidemiology, Prevention and Treatment Strategies)
►▼
Show Figures

Figure 1
Open AccessArticle
Interleukin-8 Predicts Fatal Kala-Azar: A Case–Control Study
by
Simone Soares Lima, Débora Cavalcante Braz, Vladimir Costa Silva, Teresinha de Jesus Cardoso Farias Pereira, Líndia Kalliana da Costa Araújo Alves Carvalho, Dorcas Lamounier Costa and Carlos Henrique Nery Costa
Trop. Med. Infect. Dis. 2025, 10(9), 250; https://doi.org/10.3390/tropicalmed10090250 - 1 Sep 2025
Abstract
Kala-azar is associated with case-fatality rates as high as 10% in certain regions. Early identification of mortality biomarkers can significantly reduce this risk. This study, strengthened by a relatively high number of kala-azar-related deaths, aimed to identify serum cytokines as predictive biomarkers of
[...] Read more.
Kala-azar is associated with case-fatality rates as high as 10% in certain regions. Early identification of mortality biomarkers can significantly reduce this risk. This study, strengthened by a relatively high number of kala-azar-related deaths, aimed to identify serum cytokines as predictive biomarkers of fatal kala-azar. We compared 48 deceased patients with kala-azar to 42 survivors. The concentrations of IL-1β, IL-6, IL-8, IL-10, IL-12, and tumor necrosis factor-α (TNF-α) were measured by flow cytometry. Cytokine levels were compared between groups using the Wilcoxon rank-sum test. Receiver operating characteristic (ROC) analysis, coupled with Youden’s index, defined the optimal diagnostic threshold. Upon admission, IL-8 concentrations were substantially higher in deceased kala-azar patients (median 76.5 pg/mL [IQR 35.2–242.4 pg/mL]) than in survivors (median 26.4 pg/mL [IQR 15.1–47.7 pg/mL]; p < 0.0001). ROC analysis identified 49.3 pg/mL as the optimal cutoff. When rounded to the clinically convenient value of 50 pg/mL, IL-8 predicted a fatal outcome with an area under the curve of 0.75, sensitivity of 70.8%, and specificity of 76.2%. In contrast, IL-1β, IL-6, IL-10, IL-12, and TNF-α showed no significant prognostic utility. Our findings suggest that IL-8 levels equal to or greater than 50 pg/mL are a reliable predictor of fatal kala-azar.
Full article
(This article belongs to the Section Neglected and Emerging Tropical Diseases)
►▼
Show Figures

Figure 1
Open AccessCommunication
Compatibility of Serratia ureylitica Su_YN1, Malaria Transmission-Blocking Bacterium, with the Anopheles aquasalis Vector
by
Marília Andreza da Silva Ferreira, Elen Sabrina dos Reis Martins, Ricardo de Melo Katak, Keillen Monick Martins Campos, Elerson Matos Rocha, Rosemary Aparecida Roque, Pritesh Jaychand Lalwani, Luciete Almeida Silva, Edson Júnior do Carmo, Paulo Paes de Andrade, Sibao Wang, Luciano Andrade Moreira, Marcelo Jacobs-Lorena and Claudia María Ríos-Velásquez
Trop. Med. Infect. Dis. 2025, 10(9), 249; https://doi.org/10.3390/tropicalmed10090249 - 31 Aug 2025
Abstract
Malaria continues to affect millions of people around the world. Current control strategies have not been sufficient, and additional tools are required for malaria elimination. A promising approach is the use of bacteria from the mosquito microbiota, such as the Su_YN1 Serratia ureilytica
[...] Read more.
Malaria continues to affect millions of people around the world. Current control strategies have not been sufficient, and additional tools are required for malaria elimination. A promising approach is the use of bacteria from the mosquito microbiota, such as the Su_YN1 Serratia ureilytica bacterium, which is shown to strongly impair the development of P. falciparum and P. berghei in Anopheles mosquitoes. To evaluate the potential of using S. ureilytica Su_YN1 to block the Plasmodium parasite in South American vectors, we investigated its effects on mosquito fitness and survival. We found that this bacterium does not affect the longevity, blood feeding, fecundity and fertility of Anopheles aquasalis, an important South American vector. Overall, our results provide baseline support for the potential implementation of Su_YN1 for the control of malaria transmission in South America.
Full article
(This article belongs to the Special Issue The Global Burden of Malaria and Control Strategies)
►▼
Show Figures

Figure 1
Open AccessArticle
Alcohol Consumption of Male Tuberculosis Index Cases and Tuberculosis Transmission Among Social Contacts in Puducherry, India: A Cross-Sectional Analytical Study
by
Charutha Retnakumar, Palanivel Chinnakali, Balaji Bharadwaj, Karikalan Nagarajan and Sonali Sarkar
Trop. Med. Infect. Dis. 2025, 10(9), 248; https://doi.org/10.3390/tropicalmed10090248 - 30 Aug 2025
Abstract
We aimed to compare the proportion of tuberculosis infection among social contacts of male tuberculosis Index case with and without alcohol use in the Puducherry district. A cross-sectional study using ego-centric approach was conducted between November 2023 and May 2024. A total of
[...] Read more.
We aimed to compare the proportion of tuberculosis infection among social contacts of male tuberculosis Index case with and without alcohol use in the Puducherry district. A cross-sectional study using ego-centric approach was conducted between November 2023 and May 2024. A total of 713 social contacts of 106 male pulmonary tuberculosis index cases were enrolled, stratified by alcohol-use (AUDIT ≥ 8): 358 contacts from 45 alcohol-using cases and 355 from 61 non-alcohol-use cases. Social contacts were defined based on the frequency and duration of shared indoor exposure with index cases within the past three months. Tuberculosis infection was screened with Cy-Tb skin test (≥5 mm induration) at the third month of index case treatment. Univariate and multivariable analysis were conducted to identify factors associated with tuberculosis transmission. Among the 358 social contacts of alcohol-use index cases, 33.8% (n = 121; 95% CI, 29.1–38.8%) tested positive for tuberculosis infection, significantly higher than 21.7% (n = 77; 95% CI, 17.7–26.3%) among 355 contacts of non-alcohol-use cases. Regression analysis revealed that contacts of alcohol-using index cases (aOR = 1.6, p < 0.05), were significantly associated with tuberculosis infection. Alcohol-use among tuberculosis patients significantly increases the risk of tuberculosis infection in their social networks.
Full article
(This article belongs to the Special Issue Tuberculosis Control in Africa and Asia)
►▼
Show Figures

Figure 1
Open AccessArticle
Impaired Lung Function and Quality of Life Outcomes in Patients with Tuberculosis: A Cross-Sectional Study
by
Varshini Jagadeesh, Prashanth Chikkahonnaiah, Muskan Dubey, Shashidhar H. Byrappa, Hari Balaji Sridhar, Raghavendra G. Amachawadi and Ravindra P. Veeranna
Trop. Med. Infect. Dis. 2025, 10(9), 247; https://doi.org/10.3390/tropicalmed10090247 - 29 Aug 2025
Abstract
►▼
Show Figures
Tuberculosis (TB) continues to be the world’s deadliest infectious disease, with an estimated 10.8 million new cases reported in 2023, of which India alone accounted for 28% of the global burden. This study aims to evaluate the impact of tuberculosis on pulmonary function
[...] Read more.
Tuberculosis (TB) continues to be the world’s deadliest infectious disease, with an estimated 10.8 million new cases reported in 2023, of which India alone accounted for 28% of the global burden. This study aims to evaluate the impact of tuberculosis on pulmonary function and exercise tolerance, and to examine how these impairments affect health-related quality of life (HRQoL). In a cross-sectional design, 96 bacteriologically confirmed TB patients and 96 age- and sex-matched community controls underwent spirometry, six-minute-walk test (6 MWT), and HRQoL evaluation. DR-TB was detected in 27 patients (28.1%): Isoniazid monoresistance 59.3%, rifampicin monoresistance 11.1%, and XDR-TB 29.6%. Dyspnoea (70.8%) and cough (37.5%) were the most commonly reported symptoms among TB patients. Mean values of FEV1, FVC, and FEV1/FVC were significantly lower in TB patients compared to controls (62.8%, 65.97%, and 70.08% vs. 82.55%, 80.09%, and 78.08%, respectively; p < 0.001). Recurrent or DR-TB was associated with reduced spirometric indices and 6 MWT distances (241 m vs. 358 m in drug-sensitive TB). St. George’s respiratory questionnaire (SGRQ) scores indicated significantly poorer health-related quality of life (HRQoL) in patients compared to controls across all domains—symptoms (23.7 vs. 10.7), activity (33.3 vs. 14.2), and impact (20.6 vs. 9.4; p < 0.05). SGRQ scores were inversely correlated with lung function parameters (r = −0.42 to −0.56). These findings underscore the persistent health burden TB poses post-therapy, highlighting the need for routine post-TB functional screening and robust DR-TB control to achieve End-TB goals.
Full article

Figure 1
Open AccessArticle
Diagnostic Accuracy of Antigen ELISA and Western Blot IgG for Neurocysticercosis in People Living with HIV/AIDS in Tanzania
by
Yakobo Lema, Ulrich Fabien Prodjinotho, Charles Makasi, Marrywinnie A. Nanyaro, Frank Asenga, Andrew Kilale, Sayoki Mfinanga, Charlotte Rüther, Andrea Sylvia Winkler, Eligius F. Lyamuya, Bernard J. Ngowi, Mkunde Chachage and Clarissa Prazeres da Costa
Trop. Med. Infect. Dis. 2025, 10(9), 246; https://doi.org/10.3390/tropicalmed10090246 - 29 Aug 2025
Abstract
►▼
Show Figures
Background: Neurocysticercosis (NCC) and HIV co-infection frequently occur in sub-Saharan Africa, yet the accuracy of available serological tests for NCC in immunosuppressed patients is uncertain. Methodology: We performed a cross-sectional diagnostic study on 101 people living with HIV from two endemic districts in
[...] Read more.
Background: Neurocysticercosis (NCC) and HIV co-infection frequently occur in sub-Saharan Africa, yet the accuracy of available serological tests for NCC in immunosuppressed patients is uncertain. Methodology: We performed a cross-sectional diagnostic study on 101 people living with HIV from two endemic districts in Tanzania. Participants provided serum for cysticercosis antigen ELISA and Western Blot IgG; any positive result prompted neuroimaging investigation with cerebral computed tomography. NCC was diagnosed according to the 2017 revised Del Brutto criteria based on cCT according to Del Brutto criteria modified to exclude serology. Sensitivity, specificity, and area under the receiver–operating–characteristic curve (AUC) were calculated and adjusted for CD4 count and HIV stage. Two algorithms were compared: parallel testing (“either-test-positive”) and sequential screening (Ag ELISA screen, western blot IgG confirm). Results: NCC prevalence was 23%. Western Blot IgG outperformed Ag ELISA (sensitivity 57% vs. 30%; specificity 87% vs. 86%; AUC 0.73 vs. 0.57). Western blot IgG sensitivity declined to 54% when CD4 < 500 cells µL−1, while Ag ELISA remained low. Western blot IgG positivity independently predicted NCC (adjusted odds ratio 4.1, 95% CI 1.4–11.9); Ag ELISA did not. When we counted a positive if either test was positive (parallel rule), sensitivity rose to 78% and NPV to 87%. When we ran Ag ELISA only if IgG was negative (sequential rule), we saved 70% of IgG strips, kept specificity at 95%, and PPV at 69%, but sensitivity fell to 39%. Conclusions: Western blot IgG is the most reliable single serological test for NCC in PLHIV. Parallel testing increased sensitivity and NPV and may suit better primary-level facilities without routine imaging. Sequential testing achieved high specificity, PPV, and conserved test kits, making it ideal for centers with limited reagents or scanner access. Tiered use of these assays can streamline NCC diagnosis in T. solium endemic, resource-limited settings.
Full article

Figure 1
Open AccessReview
Structural Drivers of Cutaneous Leishmaniasis: Examining How the Converging Effects of Displacement, Environmental Disruption, and Political Instability Reshape Epidemiology Beyond Endemic Regions
by
Janice Kim, Tarek Zieneldien, Sophia Ma and Bernard A. Cohen
Trop. Med. Infect. Dis. 2025, 10(9), 245; https://doi.org/10.3390/tropicalmed10090245 - 28 Aug 2025
Abstract
Cutaneous leishmaniasis (CL) is a vector-borne parasitic disease caused by protozoa of the Leishmania genus. Once confined to endemic regions such as the Middle East, Americas, North Africa, and Central Asia, CL is increasingly emerging in non-endemic areas due to a multitude of
[...] Read more.
Cutaneous leishmaniasis (CL) is a vector-borne parasitic disease caused by protozoa of the Leishmania genus. Once confined to endemic regions such as the Middle East, Americas, North Africa, and Central Asia, CL is increasingly emerging in non-endemic areas due to a multitude of drivers, including population displacement, environmental disruption, and political instability. These overlapping drivers contribute to expanding sand fly habitats, degrading living conditions, and weakening health systems, increasing transmission. Rising global temperatures further facilitate vector expansion into new regions, where clinical unfamiliarity often leads to misdiagnosis, delayed treatment, increased morbidity, and greater financial burden. Despite its rising incidence and global spread, CL remains a neglected tropical disease since it is seldom fatal, with scant interest by public health authorities and financial donors, limiting activities that further research and prevent spread of the disease. This review synthesizes current evidence on how geopolitical instability, forced migration, and climate-driven ecological changes collectively reshape CL epidemiology and complicate diagnosis, treatment, and surveillance. As CL extends beyond traditional geographic boundaries, it requires integrated strategies that address its multifaceted drivers through strengthened cross-border surveillance, provider education, and international coordination—focusing on prevention, diagnosis, and equitable access to diagnostics and therapeutics, especially among displaced and underserved populations.
Full article
(This article belongs to the Special Issue Challenges and Prevention Strategies for Travel-Related Infectious Diseases)
►▼
Show Figures

Figure 1
Open AccessArticle
Feasibility of Oral Rabies Vaccination of Dogs in Mexico
by
Verónica Gutiérrez Cedillo, Luis Antonio Montoya Mondragón, Jose Ramón Fernández Colín, Katharina Bobe, Ad Vos, Luis Armando Lecuona Olivares and Ruy López Ridaura
Trop. Med. Infect. Dis. 2025, 10(9), 244; https://doi.org/10.3390/tropicalmed10090244 - 28 Aug 2025
Abstract
Mexico has not only successfully eliminated dog-mediated human rabies in recent years, but also the last rabies case in a dog infected with the canine variant of the rabies virus was reported in 2016. Mass dog vaccination campaigns were the cornerstone of these
[...] Read more.
Mexico has not only successfully eliminated dog-mediated human rabies in recent years, but also the last rabies case in a dog infected with the canine variant of the rabies virus was reported in 2016. Mass dog vaccination campaigns were the cornerstone of these achievements. Unfortunately, the rabies virus still circulates in wildlife and, thus, spill-over infections in humans, livestock, and pets, including dogs, still occurs. Especially dogs that cohabit at interfaces shared with wildlife, like shepherd dogs, are at risk. These dogs are often free-roaming and difficult to restrain for vaccination purposes. Oral rabies vaccination (ORV) as an alternative vaccination strategy was tested in several rural villages in Querétaro State, Mexico. Bait acceptance and immunogenicity studies were conducted to test a licensed vaccine bait in terms of attractiveness and if the oral rabies vaccine strain, SPBN GASGAS, was able to induce an adequate immune response in local dogs, respectively. Although the egg(-flavored) bait was less well accepted (68.4%) by the dogs than the two other bait types included in the study, a bait made from boiled intestine segments (71.2%) and a bait with fish meal as an attractant (72.3%), dogs offered the egg bait were more often considered successfully vaccinated. 83.3% of the dogs offered an egg bait seroconverted during the immunogenicity study. Hence, ORV can be a suitable alternative by increasing the overall vaccination coverage of dogs that cannot be easily restrained and handled for vaccination.
Full article
(This article belongs to the Special Issue Tackling Emerging Zoonotic Diseases with a One Health Approach)
►▼
Show Figures

Figure 1
Open AccessArticle
Increase of Dengue in Pediatric Travelers in Madrid: A Multicentric Retrospective Experience
by
Isabel Mellado-Sola, Sonia Milkova Ivanova, Milagros García López Hortelano, Paula Rodríguez-Molino, Cinta Moraleda, Sara Otero Alambillaga, Rut Fernández Martín, Francisco José Collado Díaz, Aida Sánchez García, Inés Ojeda Velázquez, Begoña Santiago-García and Talía Sainz
Trop. Med. Infect. Dis. 2025, 10(9), 243; https://doi.org/10.3390/tropicalmed10090243 - 28 Aug 2025
Abstract
Dengue fever has significantly increased globally, extending into non-endemic regions. This study aims to describe the epidemiological and clinical characteristics of pediatric dengue cases diagnosed in Madrid, Spain, over ten years. We conducted a retrospective observational study across four tertiary hospitals, including all
[...] Read more.
Dengue fever has significantly increased globally, extending into non-endemic regions. This study aims to describe the epidemiological and clinical characteristics of pediatric dengue cases diagnosed in Madrid, Spain, over ten years. We conducted a retrospective observational study across four tertiary hospitals, including all confirmed dengue cases in children under 16 between 2015 and 2024. Epidemiological data, clinical presentation, laboratory findings, and outcomes were collected, with severity assessed according to the 2009 WHO criteria. Forty-six cases were identified, with 72% diagnosed in the last three years and a peak incidence in 2024. Children visiting friends and relatives (VFR) constituted the majority of cases (56%). The most frequent clinical features were fever (100%) and gastrointestinal symptoms (78%), while laboratory findings included leukopenia (72%), thrombocytopenia (70%), and hypertransaminasemia (74%). Five cases (10%) met the criteria for severe dengue, one being fatal in a patient with pre-existing oncological disease. We identified no autochthonous cases. These results highlight the growing impact of imported pediatric dengue in non-endemic regions, the particular vulnerability of VFR travelers, and the need for clinical awareness, improved diagnostic availability and prevention strategies, especially in climate-influenced vector expansion.
Full article
(This article belongs to the Section Travel Medicine)
►▼
Show Figures

Figure 1
Open AccessBrief Report
Epidemiological and Clinical Characteristics of Stenotrophomonas maltophilia Isolates from Hospitalized Medical Patients; An Emerging Pathogen in the Non-Critically Ill
by
Dimitrios Kouroupis, Charalampos Zarras, Maria Zarfeiadou, Christos Sanos, Elias Iosifidis, Chrysi Michailidou, Konstantina Mpani, Panagiotis Pateinakis, Theocharis Koufakis, Michail Doumas, Ioannis Goulis, Dimitrios Vlachakis and Athina Pyrpasopoulou
Trop. Med. Infect. Dis. 2025, 10(9), 242; https://doi.org/10.3390/tropicalmed10090242 - 28 Aug 2025
Abstract
Until recently, Stenotrophomonas maltophilia was considered a low-virulence pathogen, usually found as an environmental commensal and colonizer of moist abiotic surfaces. Lately, it has increasingly been implicated in invasive infections with high associated morbidity and mortality. Most epidemiological studies involving patients with S.
[...] Read more.
Until recently, Stenotrophomonas maltophilia was considered a low-virulence pathogen, usually found as an environmental commensal and colonizer of moist abiotic surfaces. Lately, it has increasingly been implicated in invasive infections with high associated morbidity and mortality. Most epidemiological studies involving patients with S. maltophilia infections have recorded risk factors and their associations with outcomes in critically ill patients. The aim of this study was to investigate its epidemiology as a pathogen in patients hospitalized in medical wards and potential factors associated with mortality. For this purpose, S. maltophilia-positive cultures from patients admitted to medical wards from 1 January 2023 to 30 June 2025 were collected, demographics and patient characteristics were recorded and analyzed and associated with clinical outcome. Twenty-nine patients and their first positive S. maltophilia positive culture were included in the study with a direct attributable mortality of 27.6%. Patients with cardiovascular and chronic obstructive pulmonary disease more commonly developed respiratory tract infections. Among the recorded comorbidities, only diabetes was associated with worse outcome. Most of the strains retained sensitivity to co-trimoxazole and levofloxacin and treatment outcome was not affected by the choice of regimen. This study highlights the rise of S. maltophilia to a true pathogen affecting immunocompetent patients; in combination with its antimicrobial resistance, this justifies its recognition as an emerging pathogen of public health concern.
Full article
(This article belongs to the Special Issue Emerging Infectious Diseases and Strategies for Their Prevention and Control)
Open AccessArticle
Identification of Statewide Hotspots for Respiratory Disease Targets Using Wastewater Monitoring Data
by
Dustin Servello, Purnima Chalasani, Erica Leasure, Krysta Danielle LeMaster, Justin Kellar, Jill Stiverson, Michelle White and Zuzana Bohrerova
Trop. Med. Infect. Dis. 2025, 10(9), 241; https://doi.org/10.3390/tropicalmed10090241 - 28 Aug 2025
Abstract
As wastewater monitoring networks continue to expand the monitoring of various targets, it is important to ensure these networks remain both representative of their monitored populations and flexible enough to accurately predict shifts in an expanding list of targets. In this study, we
[...] Read more.
As wastewater monitoring networks continue to expand the monitoring of various targets, it is important to ensure these networks remain both representative of their monitored populations and flexible enough to accurately predict shifts in an expanding list of targets. In this study, we analyzed the levels of SARS-CoV-2, influenza A (InfA), and influenza B (InfB) detected in untreated wastewater during the 2023–2024 respiratory season at 70 locations participating in the Ohio Wastewater Monitoring Network. Locations with the first detection that are seasonal hotspots and sites reaching peak concentration for each target were compared and analyzed for dependence on healthcare access and population characteristics, such as population size and density, county traffic, and demographic and socioeconomic factors. The trends in these three respiratory viruses were found to closely mirror trends in clinical indicators including the number of cases and positive tests with wastewater levels providing a two-week lead for SARS-CoV-2 and no lead for influenza on these clinical indicators. InfA was first detected in more affluent sewersheds that were less racially and ethnically diverse and had higher traffic counts, while none of the parameters tested had an effect on InfB first detects. The seasonal hotspots varied for all three respiratory viruses, where InfA hotspots were exclusively in the northeast, InfB was in the southeast and east border areas, and SARS-CoV-2 wastewater hotspots concentrated around central and northwestern Ohio. While wastewater monitoring networks may not offer full coverage of all populous areas, we have shown that a spatially distributed and highly diverse network is needed for early detection of various respiratory targets.
Full article
(This article belongs to the Special Issue Emerging and Re-emerging Infectious Diseases: Global and Local Burden, Surveillance, and Response Strategies)
►▼
Show Figures

Figure 1
Open AccessArticle
Profiling HIV Risk and Determined, Resilient, Empowered AIDS-Free, Mentored, and Safe (DREAMS) Program Reach Among Adolescent Girls and Young Women (AGYW) in Namibia: Secondary Analysis of Population and Program Data
by
Enos Moyo, Endalkachew Melese, Hadrian Mangwana, Simon Takawira, Rosalia Indongo, Bernadette Harases, Perseverance Moyo, Ntombizodwa Makurira Nyoni, Kopano Robert and Tafadzwa Dzinamarira
Trop. Med. Infect. Dis. 2025, 10(9), 240; https://doi.org/10.3390/tropicalmed10090240 - 27 Aug 2025
Abstract
Background: Namibia is experiencing a generalized HIV epidemic, with 7.5% of the population living with HIV. Adolescent girls and young women (AGYW) aged 15–24 account for 28.6% of new infections annually. Various factors increase AGYW’s vulnerability to HIV. To address this, Project HOPE
[...] Read more.
Background: Namibia is experiencing a generalized HIV epidemic, with 7.5% of the population living with HIV. Adolescent girls and young women (AGYW) aged 15–24 account for 28.6% of new infections annually. Various factors increase AGYW’s vulnerability to HIV. To address this, Project HOPE Namibia (PHN)-led consortium implemented the PEPFAR/USAID-funded DREAMS project in Khomas, Oshikoto, and Zambezi regions from 2018 to 2023. This study estimated the AGYW population most in need of HIV prevention and assessed geographic and age-specific gaps to improve program effectiveness and efficiency. Methods: This secondary data analysis utilized the Namibia Population-Based HIV Impact Assessment (NamPHIA) 2017, the Namibia census, and service data from the DREAMS project, which includes entry points for recruitment, screening, and enrolment. We used Python to conduct unadjusted and adjusted Poisson regression and UpSet plots for data visualization. Results: Analysis of NamPHIA data revealed low HIV prevalence in 10–14-year-olds, with only Oshikoto showing a detectable rate of 2.76%, mostly attributed to perinatal HIV transmission. Of the 12 DREAMS eligibility criteria, three could be mapped to 10–14-year-olds, while all except sexually transmitted infections could be mapped for 15–19 and 20–24-year-olds. Nationally, 17.3% of 10–14-year-old AGYW, 48.0% of 15–19-year-olds, and 50% of 20–24-year-olds met at least one DREAMS eligibility criterion. Among 15–19-year-olds, a history of pregnancy, no/irregular condom use, and out-of-school status were positively associated with HIV status. For 20–24-year-olds, transactional sex was positively associated with HIV status. Overall, 62% of screened individuals were eligible, and 62% of eligible individuals enrolled. PHN screened 134% of the estimated 37,965 10–14-year-olds, 95% of the estimated 35,585 15–19-year-olds, and 57% of the 24,011 20–24-year-olds residing in the five districts where DREAMS was implemented. Conclusions: We recommend the refinement of the DREAMS eligibility criteria, particularly for AGYW 10–14, to better identify and engage those at risk of HIV acquisition through sexual transmission. For 15–19-year-olds, PHN efforts should interrogate geographic variability in entry points for recruitment and screening practices. PHN should enhance the recruitment and engagement of AGYW 20–24, with a particular focus on those engaged in transactional sex.
Full article
(This article belongs to the Special Issue Leaving No One Behind: The Prevention and Treatment of HIV Among Key and Vulnerable Populations)
►▼
Show Figures

Figure 1
Open AccessArticle
Enterobacterales and Antimicrobial Resistance in Feed, Water, and Slurry in Pig Production Farms in the Greater Accra Region of Ghana, 2024
by
Elvis Fiam Amegayibor, Rita Ohene Larbi, Matilda Ayim-Akonor, Richael Odarkor Mills, Helena Owusu, Benjamin Kissi Sasu, Robert Fraser Terry, Anthony D. Harries and Florence S. Kuukyi
Trop. Med. Infect. Dis. 2025, 10(9), 239; https://doi.org/10.3390/tropicalmed10090239 - 27 Aug 2025
Abstract
Increasing antimicrobial resistance (AMR) levels in Enterobacterales from pigs in Ghana prompted us to investigate farm feed, pig slurry, and farm water for Enterobacterales isolates, their antimicrobial resistance patterns, and antimicrobial residues. Between August and November 2024, we collected one sample each of
[...] Read more.
Increasing antimicrobial resistance (AMR) levels in Enterobacterales from pigs in Ghana prompted us to investigate farm feed, pig slurry, and farm water for Enterobacterales isolates, their antimicrobial resistance patterns, and antimicrobial residues. Between August and November 2024, we collected one sample each of feed, slurry, and water from 14 pig farms for microbiological analysis. Out of 42 samples, Enterobacterales (E. coli and Enterobacter spp.) were isolated from 30 (71.4%) samples, with the highest prevalence found in feed (85.7%), followed by slurry (78.6%) and water (50.0%). The prevalence of AMR to tetracyclines, trimethoprim-sulfamethoxazole, and ampicillin was high, with over 50% of isolates from slurry and water and 40% from feed exhibiting tetracycline resistance. Multi-drug resistance (MDR) was identified in nine (27.3%) isolates of Enterobacterales, with the highest prevalence found in feed (38.5%), then slurry (23.1%), and water (14.3%). Among 42 farm samples screened for colistin-resistant Enterobacterales, 10 (23.8%) exhibited phenotypic colistin resistance. No antimicrobial residues were detected. Risk factors associated with MDR included large farms with high pig turnover (p < 0.05) and the channelling of slurry into both covered and uncovered pits on the farm (p < 0.05). These high resistance levels underscore the urgent need for improved hygiene in feed, water, and slurry management, stricter antibiotic stewardship with veterinary oversight, and better enforcement of existing antibiotic use regulations on pig farms.
Full article
(This article belongs to the Special Issue Field Impact of the SORT IT Initiative on Combating Antimicrobial Resistance Through a One Health Approach in Ghana)
►▼
Show Figures

Figure 1
Open AccessArticle
Evaluation of Hospitalizations for Tick-Borne Diseases in the United States from 2002 to 2021
by
Sidhvi Nekkanti, Kirsten Hickok, Mahesh Shrestha, Eric Edewaard and Thomas A. Melgar
Trop. Med. Infect. Dis. 2025, 10(9), 238; https://doi.org/10.3390/tropicalmed10090238 - 27 Aug 2025
Abstract
Tick-borne diseases (TBDs) are a growing public health concern in the United States. This study analyzed 261,630 weighted hospitalizations from the Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS) database between 2002 and 2021 to evaluate trends, coinfections, demographic disparities, and
[...] Read more.
Tick-borne diseases (TBDs) are a growing public health concern in the United States. This study analyzed 261,630 weighted hospitalizations from the Healthcare Cost and Utilization Project (HCUP) Nationwide Inpatient Sample (NIS) database between 2002 and 2021 to evaluate trends, coinfections, demographic disparities, and financial impacts. Lyme disease was the most common cause, accounting for 65% of hospitalizations (171,328 admissions), followed by ehrlichiosis/anaplasmosis (46,446), babesiosis (18,057), rickettsial diseases (16,412), tularemia (2428), and other TBDs (19,435). Hospitalizations increased 2.5-fold over the study period, with the Northeast region bearing 52.9% of the burden and peaking in July. Males (53.9%), Caucasians (81.4%), and residents of higher-income zip codes were predominant, though rickettsial diseases showed elevated Hispanic representation (18.4%). Coinfections were common, with 35.8% of babesiosis and 15.6% of ehrlichiosis/anaplasmosis cases involving another TBD, suggesting that routine testing may be warranted. Median hospital charges rose from USD 9433 in 2002 to USD 35,161 in 2021, totaling USD 1.265 billion in 2021. In-hospital mortality was 1.1%, with the highest cause of mortality being babesiosis (2.06%). Future areas for research include characterizing the burden of disease in an outpatient setting, understanding the causes of racial disparities in hospitalizations, and testing strategies to identify coinfection.
Full article
(This article belongs to the Special Issue The Distribution and Diversity of Tick-Borne Zoonotic Pathogens)
►▼
Show Figures

Figure 1
Open AccessArticle
Long-Term Durability and Public Health Impact of City-Wide wMel Wolbachia Mosquito Releases in Niterói, Brazil, During a Dengue Epidemic Surge
by
Katherine L. Anders, Gabriel Sylvestre Ribeiro, Renato da Silva Lopes, Pilar Amadeu, Thiago Rodrigues da Costa, Thais Irene Souza Riback, Karlos Diogo de Melo Chalegre, Wesley Pimentel de Oliveira, Cátia Cabral da Silva, Marcos Vinicius Ferreira Mendes Blanco, Ana Lucia Fontes Eppinghaus, Fabio Villas Boas, Tibor Frossard, Benjamin R. Green, Scott L. O’Neill, Peter A. Ryan, Cameron P. Simmons and Luciano A. Moreira
Trop. Med. Infect. Dis. 2025, 10(9), 237; https://doi.org/10.3390/tropicalmed10090237 - 25 Aug 2025
Abstract
In 2024, the Americas experienced the largest dengue outbreak on record and Brazil was among the worst affected countries, reporting 6.6 million cases and 6200 deaths. We report the long-term entomological and epidemiological effectiveness of city-wide deployment of wMel-strain Wolbachia-infected Aedes
[...] Read more.
In 2024, the Americas experienced the largest dengue outbreak on record and Brazil was among the worst affected countries, reporting 6.6 million cases and 6200 deaths. We report the long-term entomological and epidemiological effectiveness of city-wide deployment of wMel-strain Wolbachia-infected Aedes aegypti in Niterói, a city of half a million people in Rio de Janeiro state, where Wolbachia releases across three-quarters of the urban population in 2017–2019 were expanded to remaining populated areas in 2023. wMel was durably established at ≥95% prevalence in Ae. aegypti populations throughout Niterói four years post-release, and up to seven years in the earliest release sites. Notified dengue case incidence in Niterói was 89% lower following Wolbachia releases, compared to the 10-year pre-intervention period of 2007–2016. Dengue incidence in Niterói in 2024, during a period of record high incidence in Brazil and the region, was 374 per 100,000 population, substantially lower than overall in Rio de Janeiro state (1884 per 100,000) and nationwide in Brazil (3157 per 100,000). Our findings show that city-wide Wolbachia coverage in Niterói provided sustained population-level reduction in dengue incidence throughout the five years post-intervention, including during the 2024 epidemic surge, averting an estimated three-quarters of the dengue case burden that may otherwise have been expected in Niterói in 2024.
Full article
(This article belongs to the Section Vector-Borne Diseases)
►▼
Show Figures

Figure 1
Open AccessReview
Quantitative Methods for Evaluating Antibody Responses to Pneumococcal Vaccines: A Scoping Review
by
Yumiko Hayashi, Fleurette Mbuyakala Domai and Bhim Gopal Dhoubhadel
Trop. Med. Infect. Dis. 2025, 10(8), 236; https://doi.org/10.3390/tropicalmed10080236 - 21 Aug 2025
Abstract
Streptococcus pneumoniae remains a leading cause of invasive diseases, particularly affecting young children and the elderly. Currently, two main types of pneumococcal vaccines are commercially available: polysaccharide vaccine (PPSV23) and conjugate vaccines (e.g., PCV20). Of over 100 identified pneumococcal serotypes, vaccines targeting 24
[...] Read more.
Streptococcus pneumoniae remains a leading cause of invasive diseases, particularly affecting young children and the elderly. Currently, two main types of pneumococcal vaccines are commercially available: polysaccharide vaccine (PPSV23) and conjugate vaccines (e.g., PCV20). Of over 100 identified pneumococcal serotypes, vaccines targeting 24 serotypes covered by PPSV23 and PCV20 (19 serotypes overlap between the two vaccines) have been developed, with serotype distribution varying by geography, age, and time. The immune response to pneumococcal vaccines differs across serotypes, vaccine types (polysaccharide vs. conjugate), and host factors. Quantitative methods for antibody assessment—particularly newer high-throughput assays—have emerged since 2000 to address limitations in conventional approaches. However, these methods have not been comprehensively reviewed. This scoping review aimed to systematically map the existing literature on quantitative methods used to assess antibody responses to pneumococcal vaccines. Specific objectives included the following: 1. summarizing conventional and novel quantitative immunoassays; 2. evaluating the current state of validation and application of these methods; 3. identifying knowledge gaps and methodological challenges. We followed the PRISMA-ScR guidelines. We included the following: 1. peer-reviewed, open-access papers related to immunoassays used for pneumococcal antibody assessment; 2. articles written in English; 3. Studies published between 2000 and 2023. We excluded the following: 4. studies focusing on other pathogens, employing different analytical methods, or using animal models. Articles meeting the eligibility criteria were primarily retrieved from PubMed and Scopus. If free full-text versions were unavailable there, Google Scholar or the original journal databases were consulted. All references were exported to EndNote 20 for further management. At the beginning of the review, a data-charting form was developed based on prior studies and commonly addressed themes. Additional charts were created to accommodate newly identified variables during the review. All charting tools were reviewed and finalized through discussion among all research team members. The included studies were classified into five thematic groups: 1. general descriptions of quantitative assessment methods, 2. assay development and validation, 3. comparative studies, 4. technical details of assay development, 5. interpretation of assay application findings. Of 1469 articles from PubMed and 2946 articles from Scopus initially identified, 55 articles met the inclusion criteria. The earliest methods included radioimmunoassays, later replaced by WHO-standardized ELISA. While ELISA remains the gold standard, it is limited by labor, cost, and throughput. Multiplex immunoassays (MIAs), including Luminex-based platforms, have demonstrated advantages in efficiency and scalability. However, many MIAs did not initially meet WHO validation criteria. More recent assays show an improved performance, yet interlaboratory variability and lack of standardized protective thresholds remain major limitations. This review provides the first comprehensive mapping of quantitative antibody assessment methods for pneumococcal vaccines. Although ELISA continues to serve as the benchmark, MIAs represent a promising next-generation approach. Continued efforts are needed to harmonize assay validation protocols and establish global standards for protective thresholds, which will enhance the reliability of vaccine efficacy monitoring across diverse populations.
Full article
(This article belongs to the Section Infectious Diseases)
►▼
Show Figures

Figure 1
Open AccessArticle
Screening for Latent Tuberculosis Across Chronic Kidney Disease Stages Using Interferon-Gamma Release Assay: Findings from a National Infectious Disease Institute in Thailand
by
Wannarat Pongpirul, Krit Pongpirul, Vongsatorn Tiabrat, Karnsuwee Muennoo and Wisit Prasithsirikul
Trop. Med. Infect. Dis. 2025, 10(8), 235; https://doi.org/10.3390/tropicalmed10080235 - 20 Aug 2025
Abstract
Background: Latent tuberculosis infection (LTBI) is a major global health concern, particularly among individuals with chronic kidney disease (CKD), who are at increased risk of reactivation due to impaired immunity and frequent exposure to immunosuppressive therapies. Despite growing reliance on interferon-gamma release assays
[...] Read more.
Background: Latent tuberculosis infection (LTBI) is a major global health concern, particularly among individuals with chronic kidney disease (CKD), who are at increased risk of reactivation due to impaired immunity and frequent exposure to immunosuppressive therapies. Despite growing reliance on interferon-gamma release assays (IGRAs) such as QuantiFERON-TB Gold In-Tube (QFT-GIT) in BCG-vaccinated populations, data on IGRA performance across CKD stages remain limited in resource-limited settings. Objective: To determine the prevalence of LTBI and indeterminate IGRA results across CKD stages in a Thai population and assess the clinical utility of IGRA in this context. Materials and Methods: We conducted a cross-sectional study among 785 Thai adults receiving care at a national infectious disease institute, including diabetes clinic patients, hospital staff, and individuals on hemodialysis. Each participant underwent QFT-GIT testing, and the CKD stage was classified using the estimated glomerular filtration rate (eGFR) closest prior to testing. Results: Overall IGRA positivity was 22.2%, peaking in CKD stage G3 (31.6%) and declining in stage G5 (11.0%), where indeterminate results were also highest (6.8%). Limitations: Single-center design and lack of confirmatory testing may limit generalizability. Conclusions: IGRA performance is reliable in early-to-moderate CKD but less so in advanced stages. LTBI is prevalent in CKD stages G2–G4, supporting stage-specific approaches to LTBI screening and caution against overreliance on IGRA in advanced renal impairment.
Full article
(This article belongs to the Special Issue Tuberculosis in Special Populations: Epidemiology and Evidence-Based Interventions)
Open AccessArticle
Evaluation of Allplex™ GI-Parasite Assay—A Multiplex Real Time PCR for the Diagnosis of Intestinal Protozoa: A Multicentric Italian Study
by
Ester Oliva, Libera Clemente, Nicola Menegotto, Stefania Varani, Antonella Bruno, Raffaele Gargiulo, Luciana Petrullo, Claudio Farina and Annibale Raglio
Trop. Med. Infect. Dis. 2025, 10(8), 234; https://doi.org/10.3390/tropicalmed10080234 - 19 Aug 2025
Abstract
Background: The microscopic examination of stool samples remains the reference method for the diagnosis of intestinal protozoal infections; however, this technique is time consuming and requires experienced and well-trained operators. Therefore, there is a growing interest in molecular diagnostic techniques, including commercial PCR
[...] Read more.
Background: The microscopic examination of stool samples remains the reference method for the diagnosis of intestinal protozoal infections; however, this technique is time consuming and requires experienced and well-trained operators. Therefore, there is a growing interest in molecular diagnostic techniques, including commercial PCR assays. The aim of this multicentric study was to evaluate a commercial real-time PCR for the detection of intestinal protozoa in fecal samples. Methods: The samples were routinely examined using conventional techniques, such as macro- and microscopic examination after concentration, Giemsa or Trichromic stain, Giardia duodenalis, Entamoeba histolytica/dispar or Cryptosporidium spp. antigens research, and amoebae culture. The samples were frozen by the participating laboratories, retrospectively extracted and examined with one-step real-time PCR multiplex using the Allplex™ GI-Parasite Assay (Seegene Inc., Seoul, Korea). Results: A total of 368 samples were analyzed from 12 Italian laboratories. Compared to traditional techniques, the sensibility and specificity of the real-time PCR kit were as follows: 100% and 100% for Entamoeba histolytica, 100% and 99.2% for Giardia duodenalis, 97.2% and 100% for Dientamoeba fragilis, and 100% and 99.7% for Cryptosporidium spp., respectively. Conclusions: The Allplex™ GI-Parasite Assay exhibited excellent performance in the detection of the most common enteric protozoa.
Full article
(This article belongs to the Special Issue Advances in Molecular Diagnosis in Neglected Tropical Diseases)
►▼
Show Figures

Figure 1
Open AccessArticle
Prognostic Indicators of Severe Dengue Infection in Adult Patients in Thailand
by
Patcharin Khamnuan, Surangrat Pongpan, Pantitcha Thanatrakolsri, Supa Vittaporn, Punnaphat Daraswang and Sirawan Samsee
Trop. Med. Infect. Dis. 2025, 10(8), 233; https://doi.org/10.3390/tropicalmed10080233 - 18 Aug 2025
Abstract
Background: Dengue infection is a spreading vector borne disease with most severe infection-related fatalities occurring in adults. This study was conducted to explore prognostic indicators of dengue infection severity. Methods: This study included patients aged over 15 years who were diagnosed with dengue
[...] Read more.
Background: Dengue infection is a spreading vector borne disease with most severe infection-related fatalities occurring in adults. This study was conducted to explore prognostic indicators of dengue infection severity. Methods: This study included patients aged over 15 years who were diagnosed with dengue viral infection. Data were collected from nine hospitals across all regions of Thailand between January 2019 and December 2022. Diagnosis of dengue infection was confirmed by a positive result for the NS-1 antigen via RT–PCR, IgM antibody, or IgG antibody tests. Data including gender, age, BMI, underlying disease, clinical characteristics and laboratory findings were collected. Multivariable logistic regression with backward elimination was used to identify a set of prognostic factors. Results: The prognostic indicators of severe dengue were age < 55 years (OR = 6.13, p = 0.054), severe bleeding (bleeding from the gastrointestinal tract, hematemesis, melena, menorrhagia, or hematuria) (OR = 20.75, p < 0.001), pleural effusion (OR = 10.23, p < 0.001), and platelet ≤ 100,000 (/µL) (OR = 3.62, p = 0.035). These predictors were able to accurately estimate the severity of dengue infection with an area under the receiver operating curve (AuROC) of 0.836. Conclusions: The proposed four prognostic factors can be applied to predict severe dengue infections. These findings may inform the development of a risk scoring system to forecast severe dengue infection, early detection, and appropriate treatment during sickness.
Full article
(This article belongs to the Special Issue One Health Approach to Mosquito-Borne Diseases: Epidemiology, Prevention and Treatment Strategies)
►▼
Show Figures

Figure 1

Journal Menu
► ▼ Journal Menu-
- TropicalMed Home
- Aims & Scope
- Editorial Board
- Topical Advisory Panel
- Instructions for Authors
- Special Issues
- Topics
- Sections & Collections
- Article Processing Charge
- Indexing & Archiving
- Editor’s Choice Articles
- Most Cited & Viewed
- Journal Statistics
- Journal History
- Journal Awards
- Society Collaborations
- Conferences
- Editorial Office
Journal Browser
► ▼ Journal BrowserHighly Accessed Articles
Latest Books
E-Mail Alert
News
Topics
Topic in
Infectious Disease Reports, Insects, IJERPH, Pathogens, TropicalMed, Zoonotic Diseases
Vector-Borne Disease Spatial Epidemiology, Disease Ecology, and Zoonoses
Topic Editors: Chad L. Cross, Louisa Alexandra MessengerDeadline: 31 December 2025
Topic in
IJERPH, TropicalMed, Microorganisms, Infectious Disease Reports, Pathogens
Genetic, Environmental, and Climatic Drivers of Emerging Arboviruses and Public Health Implications
Topic Editors: André Ricardo Ribas Freitas, Pedro María Alarcón-Elbal, Luciano Pamplona de Góes CavalcantiDeadline: 20 January 2027

Conferences
Special Issues
Special Issue in
TropicalMed
Diagnosis and Treatment of Multidrug-Resistant Tuberculosis: Insights from New Research and Clinical Trials
Guest Editors: Felipe Ridolfi, María Belen Arriaga Gutiérrez, Juan P. Aguilar TiconaDeadline: 15 September 2025
Special Issue in
TropicalMed
Advances in Toxoplasma gondii Infection Research
Guest Editors: Imaan Benmerzouga, Juan Atilio Jimenez ChungaDeadline: 15 September 2025
Special Issue in
TropicalMed
Infectious Disease Epidemiology and Interventions in Carceral Settings of Low- and Middle-Income Countries
Guest Editors: Anne Spaulding, Lawrence Kofi Acheampong, Osei Owusu-AfriyieDeadline: 28 September 2025
Special Issue in
TropicalMed
Adolescent HIV Care and Transition Strategies: Challenges, Outcomes, and Interventions
Guest Editor: Brian C. ZanoniDeadline: 30 September 2025
Topical Collections
Topical Collection in
TropicalMed
Infection Prevention and Control: Practical and Educational Advances
Collection Editors: Constantinos Tsioutis, Spyridon Karageorgos, Nico Mutters, Carlos Palos